Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Lizza E. L. Hendriks"'
Autor:
Iva Halilaj, Anshu Ankolekar, Anouk Lenaers, Avishek Chatterjee, Cary J. G. Oberije, Lisanne Eppings, Hans J. M. Smit, Lizza E. L. Hendriks, Arthur Jochems, Relinde I. Y. Lieverse, Janita E. van Timmeren, Anke Wind, Philippe Lambin
Publikováno v:
Frontiers in Digital Health, Vol 5 (2024)
The aim of this study was to develop and evaluate a proof-of-concept open-source individualized Patient Decision Aid (iPDA) with a group of patients, physicians, and computer scientists. The iPDA was developed based on the International Patient Decis
Externí odkaz:
https://doaj.org/article/e12bdf591cc24ee2aa47f5ffbb7db295
Autor:
Valentina Bartolomeo, Mandy Jongbloed, Wouter R. P. H. van de Worp, Ramon Langen, Juliette Degens, Lizza E. L. Hendriks, Dirk K. M. de Ruysscher
Publikováno v:
Cancers, Vol 16, Iss 1, p 230 (2024)
Among patients with advanced NSCLC, there is a group of patients with synchronous oligometastatic disease (sOMD), defined as a limited number of metastases detected at the time of diagnosis. As cachexia and sarcopenia are linked to poor survival, inc
Externí odkaz:
https://doaj.org/article/0753155a23d049689d999bd0840b1ff0
Autor:
Zhixiang Wang, Zhen Zhang, Ying Feng, Lizza E. L. Hendriks, Razvan L. Miclea, Hester Gietema, Janna Schoenmaekers, Andre Dekker, Leonard Wee, Alberto Traverso
Publikováno v:
European Radiology Experimental, Vol 6, Iss 1, Pp 1-12 (2022)
Abstract Background Data shortage is a common challenge in developing computer-aided diagnosis systems. We developed a generative adversarial network (GAN) model to generate synthetic lung lesions mimicking ground glass nodules (GGNs). Methods We use
Externí odkaz:
https://doaj.org/article/e0cf50d997d54f8c81e2bb374ed74cf4
Autor:
Naomi C. A. van der Velden, Hanneke W. M. van Laarhoven, Sjaak A. Burgers, Lizza E. L. Hendriks, Filip Y. F. L. de Vos, Anne-Marie C. Dingemans, Joost Jansen, Jan-Maarten W. van Haarst, Joyce Dits, Ellen MA Smets, Inge Henselmans
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background For some patients with advanced cancer not knowing prognosis is essential. Yet, in an era of informed decision-making, the potential protective function of unawareness is easily overlooked. We aimed to investigate 1) the proportio
Externí odkaz:
https://doaj.org/article/6d4c5128f8fe44f6b62fc9aaba415b37
Autor:
Sergey P. Primakov, Abdalla Ibrahim, Janita E. van Timmeren, Guangyao Wu, Simon A. Keek, Manon Beuque, Renée W. Y. Granzier, Elizaveta Lavrova, Madeleine Scrivener, Sebastian Sanduleanu, Esma Kayan, Iva Halilaj, Anouk Lenaers, Jianlin Wu, René Monshouwer, Xavier Geets, Hester A. Gietema, Lizza E. L. Hendriks, Olivier Morin, Arthur Jochems, Henry C. Woodruff, Philippe Lambin
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
Correct interpretation of computer tomography (CT) scans is important for the correct assessment of a patient’s disease but can be subjective and timely. Here, the authors develop a system that can automatically segment the non-small cell lung canc
Externí odkaz:
https://doaj.org/article/f8d1b5e497c446468d70f52ae1ba8e78
Autor:
Marinda Meertens, M. Benthe Muntinghe-Wagenaar, Barend J. Sikkema, Marta Lopez-Yurda, Valesca P. Retèl, Marthe S. Paats, Rob Ter Heine, Ed Schuuring, Wim Timens, Daan J. Touw, Job F. M. van Boven, Adrianus. J. de Langen, Sayed M. S. Hashemi, Lizza E. L. Hendriks, Sander Croes, Michel M. van den Heuvel, Anne-Marie C. Dingemans, Ron H. J. Mathijssen, Egbert F. Smit, Alwin D. R. Huitema, Neeltje Steeghs, Anthonie J. van der Wekken
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundAlectinib is first-line therapy in patients with stage IV non-small cell lung carcinoma (NSCLC) and an anaplastic lymphoma kinase (ALK) fusion. A shorter median progression-free survival (mPFS) was observed when alectinib minimum plasma con
Externí odkaz:
https://doaj.org/article/4457ff0cdd7b4bd9aa0922759784c7a7
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Consolidation anti-programmed death-ligand 1 has become a new standard of care in unresectable stage III non-small cell lung cancer (NSCLC) following chemo-radiotherapy (CTRT), based on the results of two phase III trials. Advances remain however nee
Externí odkaz:
https://doaj.org/article/e69d3240bc0146f489f2307caaa37602
Autor:
Simon A. Keek, Manon Beuque, Sergey Primakov, Henry C. Woodruff, Avishek Chatterjee, Janita E. van Timmeren, Martin Vallières, Lizza E. L. Hendriks, Johannes Kraft, Nicolaus Andratschke, Steve E. Braunstein, Olivier Morin, Philippe Lambin
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionThere is a cumulative risk of 20–40% of developing brain metastases (BM) in solid cancers. Stereotactic radiotherapy (SRT) enables the application of high focal doses of radiation to a volume and is often used for BM treatment. However,
Externí odkaz:
https://doaj.org/article/a29dd364d66744579caa9035f29aaa08
Autor:
Haiyan Zeng, Danyang Zheng, Willem J. A. Witlox, Antonin Levy, Alberto Traverso, Feng-Ming (Spring) Kong, Ruud Houben, Dirk K. M. De Ruysscher, Lizza E. L. Hendriks
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The use of prophylactic cranial irradiation (PCI) for small cell lung cancer (SCLC) patients is controversial. Risk factors for brain metastasis (BM) development are largely lacking, hampering personalized treatment strategies. This study aimed to id
Externí odkaz:
https://doaj.org/article/c55bdab3374f4d1da01c0ea78010340a
Autor:
Haiyan Zeng, Fariba Tohidinezhad, Dirk K. M. De Ruysscher, Yves C. P. Willems, Juliette H. R. J. Degens, Vivian E. M. van Kampen-van den Boogaart, Cordula Pitz, Francesco Cortiula, Lloyd Brandts, Lizza E. L. Hendriks, Alberto Traverso
Publikováno v:
Cancers, Vol 15, Iss 11, p 3010 (2023)
Purpose: To identify clinical risk factors, including gross tumor volume (GTV) and radiomics features, for developing brain metastases (BM) in patients with radically treated stage III non-small cell lung cancer (NSCLC). Methods: Clinical data and pl
Externí odkaz:
https://doaj.org/article/367a4d0cdac4476eb1ec7f8bd96e2150